The Scoop That Ate the Gym
In the autumn of 2015, a Swiss-American nutrition conglomerate called Glanbia — the publicly traded owner of Optimum Nutrition and BSN, two of the most recognized supplement brands on the planet — was presented with an acquisition opportunity that its board ultimately declined. The target was a Manchester-based online protein retailer called Myprotein, then doing roughly £250 million in annual revenue, selling whey in pouches that looked more like pet food than performance nutrition, with margins that made the legacy sports nutrition industry wince. The asking price was too high relative to the brand's wholesale positioning, Glanbia's advisors concluded. The brand lacked the "premiumness" required for a global rollout.
Within eighteen months, The Hut Group — a British e-commerce conglomerate run by a former Tesco supply chain analyst named Matthew Moulding — had acquired Myprotein for a reported £58 million, folded it into a proprietary technology stack called Ingenuity, and begun executing a playbook that would turn the brand into the largest online sports nutrition retailer on Earth. By 2023, Myprotein alone was generating more than £600 million in revenue, shipping to over 70 countries, and had become the financial engine that justified THG's entire public listing on the London Stock Exchange at a peak valuation exceeding £5.5 billion. The gym bro brand that Glanbia passed on had, through the alchemy of direct-to-consumer infrastructure, relentless price compression, and algorithmic promotional intensity, become the single most consequential case study in how commodity nutrition gets transmuted into platform economics.
But here is the tension that makes the Myprotein story something more than a growth-company hagiography: the very machine that built the brand — perpetual discounting, vertically integrated fulfillment, and a technology platform whose ambitions extended far beyond protein powder — nearly destroyed the parent company that housed it. THG's stock would collapse more than 90% from its IPO highs. Governance controversies swirled around Moulding's dual roles as CEO and landlord to his own company. And Myprotein itself, the crown jewel, would face the existential question that every DTC brand eventually confronts: can you build a real brand on a foundation of 55%-off flash sales and SEO arbitrage, or have you merely trained your customers to never pay full price?
The answer, it turns out, is more interesting than either the bulls or the bears expected.
By the Numbers
Myprotein at Scale
£600M+Estimated annual revenue (2023)
70+Countries served via DTC e-commerce
2,500+Products in the active catalog
~45%Estimated gross margin on core whey
13M+Active customer accounts globally
£58MAcquisition price by THG (2016)
2004Year founded in Manchester
Oliver Cookson's Bedroom Arbitrage
Every sports nutrition origin story involves a gym. Myprotein's involves a spreadsheet. Oliver Cookson was not a bodybuilder or a competitive athlete when he registered the domain myprotein.co.uk in 2004. He was a 21-year-old from Manchester who had studied business, understood that the UK supplement market was structured almost identically to the wine market before direct-to-consumer shipping disrupted it — a web of distributors, importers, and retail markups that inflated the price of a commodity input (whey protein concentrate, a byproduct of cheese production trading at roughly £3–5 per kilogram) into a £30–50 retail tub bearing the logo of an American bodybuilding brand.
Cookson's insight was deceptively simple: skip all of it. Source whey directly from European dairies, package it in minimalist resealable pouches instead of rigid plastic tubs (saving roughly 40% on packaging costs), sell exclusively online, and price the product at 30–50% below retail competitors. The pouches looked cheap because they were cheap. That was the point. The early Myprotein customer was a self-selecting cohort of price-sensitive, internet-literate gym-goers — overwhelmingly male, 18–34, living in the UK — who understood that Impact Whey Protein and Optimum Nutrition Gold Standard were functionally identical products separated by a branding premium and a distribution chain.
The company operated out of Cookson's apartment for its first year, then moved into a small warehouse in Cheshire. There was no venture capital, no institutional backing, no retail presence. Growth was organic, driven almost entirely by bodybuilding forums, early supplement review sites, and the nascent fitness influencer ecosystem on YouTube. Cookson reinvested every pound of profit into inventory, gradually expanding from whey protein into a full catalog of commodity sports nutrition inputs — creatine, BCAAs, pre-workouts, protein bars, peanut butter — all sold under the Myprotein house brand, all priced to undercut.
By 2011, Myprotein was the largest online sports nutrition retailer in the UK, generating approximately £70 million in revenue. Cookson had built something rare: a profitable, bootstrapped, direct-to-consumer business with genuine repeat purchase behavior and no dependency on wholesale distribution. He had also, without quite realizing it, built a template that a much more ambitious operator would recognize as a platform.
I never wanted to build a brand that sat on a shelf at Holland & Barrett. I wanted to own the relationship with the customer, because that's where all the margin lives.
— Oliver Cookson, interview with Manchester Evening News, 2016
The Hut Group's Appetite
Matthew Moulding is the kind of figure who, in American business culture, would be called a visionary and, in British business culture, is called suspicious. A Burnley native who studied at the University of Nottingham, Moulding cut his teeth in supply chain and logistics at Tesco before working briefly in private equity. He founded The Hut Group in 2004 — the same year Cookson registered myprotein.co.uk — initially as an online retailer of CDs and DVDs, a category that was, to put it mildly, not long for this world.
But Moulding wasn't interested in CDs. He was interested in the plumbing. THG's earliest innovation was its proprietary e-commerce infrastructure — a technology stack built in-house that handled everything from website rendering and checkout to warehousing, fulfillment, and localized payment processing across dozens of markets. By 2010, Moulding had pivoted THG into a holding company for direct-to-consumer brands, primarily in beauty (Lookfantastic, Grow Gorgeous) and nutrition. The technology platform, which he would eventually brand as "Ingenuity," was the connective tissue — the operating system that allowed THG to acquire a brand, migrate it onto Ingenuity's infrastructure within weeks, and immediately gain the benefits of centralized fulfillment, multi-market localization, and THG's proprietary marketing and pricing engine.
When Moulding acquired Myprotein in 2016 for £58 million, Cookson had already scaled the brand to roughly £150 million in revenue. But Moulding saw something Cookson hadn't optimized for: international expansion. Myprotein was overwhelmingly a UK business, with tentative footholds in a few European markets. Moulding's thesis was that Ingenuity could take a brand that had proven product-market fit in one geography and replicate it across dozens of markets simultaneously — launching localized websites, establishing regional fulfillment nodes, running country-specific promotions, and managing multi-currency pricing — at a speed and cost that no traditional CPG company could match.
The results were staggering. Within three years of the acquisition, Myprotein's revenue had more than doubled. The brand launched dedicated operations in Japan, South Korea, China (via Tmall), India, the Middle East, and across continental Europe. By 2020, international markets represented over 50% of Myprotein's revenue, up from approximately 15% at the time of acquisition. The Ingenuity platform had done exactly what Moulding promised: turned a UK-centric online retailer into a global DTC nutrition brand with the operational footprint of a company ten times its age.
🏭
THG's Myprotein Expansion
Key milestones after the 2016 acquisition
2016THG acquires Myprotein for £58M; begins Ingenuity migration.
2017Launches localized sites in 12 new markets including Japan, Singapore, and Germany.
2018Opens dedicated fulfillment center in Poland for European distribution.
2019Enters China via Tmall Global; revenue crosses £400M.
2020COVID-19 home fitness boom drives 40%+ YoY growth; international surpasses 50% of revenue.
2021THG IPOs on London Stock Exchange; Myprotein identified as the "core growth engine."
2023Revenue exceeds £600M; 2,500+ SKUs across nutrition, clothing, and accessories.
The Discount Machine
To understand Myprotein's commercial engine, you have to understand a single, uncomfortable fact: the company's "regular" prices are a fiction. Not a soft fiction, not a gentle markup-to-markdown dance of the kind practiced by department stores. A structural fiction. Myprotein's stated retail prices exist primarily to make its perpetual promotional prices look like extraordinary value. Visit the Myprotein website on any given Tuesday in any given month and you will find a sitewide discount of 40–55%, a stacking code for an additional 5–10% off, and free shipping thresholds calibrated to nudge basket sizes upward. The "sale" never ends because there is no non-sale state.
This is not an accident. It is the business model.
Myprotein's pricing architecture is built on the insight that sports nutrition consumers — particularly the core demographic of 18–34-year-old men who consume protein powder as a near-daily staple — are among the most price-elastic customers in consumer packaged goods. They know the cost of whey. They can compare per-gram protein costs across brands in seconds. They will switch for a 10% price differential. In this environment, the traditional CPG playbook of building brand equity through aspirational marketing and charging premium prices is structurally disadvantaged. Myprotein's approach inverts it: build brand equity through value perception, make the customer feel like they're getting away with something, and monetize through volume and repeat purchase frequency rather than per-unit margin.
The mathematics work like this. Myprotein's cost of goods on a 1kg pouch of Impact Whey Protein — including whey procurement, flavoring, manufacturing, and packaging — sits in the range of £5–8 depending on whey spot prices and flavor complexity. The "retail" price is listed at approximately £25.99. The effective selling price, after the omnipresent discount, lands in the £12–16 range. That yields a product-level gross margin of roughly 50–65%, which is comparable to or better than the margins Optimum Nutrition achieves on its £30+ tubs sold through retail channels — because Myprotein pays no wholesale margin, no retailer margin, and minimal packaging cost. The discount is not eroding margin. The discount is the margin strategy, because it eliminates the intermediary costs that traditional sports nutrition brands absorb.
The risk, of course, is that you train an entire customer base to never buy without a code. Myprotein has done precisely this. Internal data leaked during THG's post-IPO governance controversies suggested that fewer than 5% of Myprotein transactions occur at full price. The company's email marketing cadence — multiple promotional emails per day to active customers — is among the most aggressive in any DTC category. This creates a treadmill effect: promotional intensity must increase to maintain conversion rates, because customers anchor to previous discounts and delay purchases until a better offer arrives. By 2022, industry analysts were observing that Myprotein's effective average discount had crept from roughly 35% in 2018 to over 45% in 2022, compressing the net revenue per unit even as headline revenue grew.
The machine works brilliantly until it doesn't. You're always one discount cycle away from the customer realizing they should just wait another week for a better code.
— Anonymous former THG commercial director, Business of Fashion, 2022
The Protein Wars: Commodity, Category, and the Illusion of Differentiation
Sports nutrition is a peculiar market. It sits at the intersection of three consumer categories — food, health, and fitness — yet behaves like none of them. The core product, whey protein, is a commodity with transparent input costs, minimal regulatory barriers, and near-zero switching costs for consumers. And yet the global sports nutrition market was valued at approximately $45 billion in 2023, growing at 7–9% annually, with hundreds of brands coexisting at wildly different price points selling functionally equivalent products.
The structural explanation is that sports nutrition brands are not really selling nutrition. They are selling identity, ritual, and belonging. Optimum Nutrition sells the identity of the serious lifter. Ghost sells the identity of the gamer-meets-gym-bro. Gymshark's nutrition line (launched 2022) sells the identity of the aesthetic fitness influencer. And Myprotein, whether it intended to or not, sells the identity of the smart consumer — the person who refuses to pay a brand tax on a commodity.
This positioning is both Myprotein's greatest strength and its most significant vulnerability. The "smart value" customer is, almost by definition, the least loyal customer. They are optimizing on price, and if a competitor can undercut Myprotein — or if Amazon's private-label sports nutrition line achieves sufficient quality perception — the smart value customer will migrate without sentiment. Myprotein's response to this risk has been a multi-year effort to move upmarket through product line extensions: clear whey isolate (a higher-margin, higher-quality product launched in 2019 that became a viral sensation), collagen peptides, plant-based proteins, ready-to-drink formats, and a full athleisure clothing line called MP Clothing. Each extension attempts to create switching costs and emotional attachment that commodity whey powder cannot.
The clear whey innovation is worth pausing on. Launched as a limited-edition SKU in 2019, Myprotein's Clear Whey Isolate — a juice-like protein drink made from hydrolyzed whey isolate rather than the traditional milky shake format — became one of the most successful product launches in sports nutrition history. It went viral on TikTok, generated hundreds of millions of organic impressions, and became Myprotein's highest-margin product line, commanding a per-serving premium of roughly 40% over standard Impact Whey. More importantly, it demonstrated that Myprotein was capable of genuine product innovation, not merely cost arbitrage. Clear whey now accounts for an estimated 15–20% of Myprotein's nutrition revenue and has been copied by virtually every competitor in the category.
The Ingenuity Question
The story of Myprotein cannot be separated from the story of THG's technology platform, because the platform was both the vehicle for Myprotein's global expansion and the source of the corporate governance crisis that nearly unwound the entire enterprise.
THG's Ingenuity platform was pitched to public markets as a SaaS-like technology business — a Shopify for beauty and nutrition brands, capable of powering end-to-end DTC operations for third-party clients. Moulding argued that Ingenuity's value should be assessed independently of THG's own brand portfolio, implying a technology multiple rather than a retail multiple for the parent company. This narrative was central to THG's IPO in September 2020, when the company listed on the London Stock Exchange at a valuation of approximately £5.4 billion.
The market believed it. Briefly.
Within eighteen months, a combination of factors eroded the Ingenuity thesis. Short sellers, most notably ShadowFall Capital, published detailed reports questioning whether Ingenuity had any meaningful third-party revenue independent of THG's own brands. Governance concerns intensified when it emerged that Moulding personally owned several of the warehouses that THG leased, creating potential conflicts of interest. The company's decision to list with a "special share" structure that gave Moulding a golden share — effectively a veto over any takeover — further alienated institutional investors. By October 2021, THG's share price had fallen over 60% from its IPO high. By late 2022, it had fallen over 90%.
For Myprotein, the corporate chaos was a paradox. The brand's operational performance remained strong throughout — revenue continued to grow, customer acquisition remained healthy, and the international expansion showed no signs of decelerating. But the parent company's collapsing valuation and governance controversies created a shadow over the brand. Recruitment became harder. Supplier negotiations grew more tense. And the perpetual question hung in the air: would THG be forced to sell Myprotein to satisfy creditors or placate shareholders?
In 2023 and 2024, THG began a strategic restructuring that effectively acknowledged the market's verdict. Moulding relinquished the golden share. The company reorganized into three distinct divisions — THG Beauty, THG Nutrition (anchored by Myprotein), and THG Ingenuity — with the explicit goal of making each unit independently evaluable and, potentially, independently saleable. Myprotein, the asset that had justified the entire corporate edifice, was now being positioned as a standalone entity, valued by analysts at £1–2 billion — a remarkable figure for a brand acquired for £58 million seven years earlier, but a fraction of what THG's peak market capitalization had implied.
Myprotein is the number one online sports nutrition brand globally. That is not a claim — it is a statement of fact supported by third-party data. The brand's trajectory is independent of any corporate structure question.
— Matthew Moulding, THG Capital Markets Day, March 2023
The Geography of Protein
One of the least appreciated aspects of Myprotein's competitive advantage is its fulfillment topology. While most DTC brands outsource logistics to third-party fulfillment providers (3PLs) or rely on Amazon's FBA network, Myprotein operates a vertically integrated supply chain that spans from raw material sourcing through to last-mile delivery in most of its core markets.
The backbone is a network of owned and leased facilities. The primary manufacturing and fulfillment hub is a 750,000-square-foot facility in Warrington, England, where Myprotein produces a significant portion of its powder, bar, and snack products in-house. This vertical integration into manufacturing — unusual for a DTC brand of any category — gives Myprotein direct control over formulation, quality, and cost of goods. A second major fulfillment center in Łódź, Poland, serves continental European markets, reducing delivery times and avoiding the post-Brexit customs complications that bedeviled UK-based e-commerce operators. Additional fulfillment nodes operate in the United States (via a partnership facility), Asia-Pacific, and the Middle East.
The strategic logic is straightforward: in commodity categories, fulfillment speed and cost are primary competitive weapons. A customer choosing between Myprotein and a competitor offering similar pricing will default to whichever brand delivers faster and cheaper. Myprotein's owned infrastructure allows it to offer next-day delivery in the UK and 2–3 day delivery across most of Europe at shipping costs that third-party-dependent competitors cannot match. The Warrington facility's in-house manufacturing capability means Myprotein can launch new flavors and SKUs in weeks rather than the months required by brands dependent on contract manufacturers.
This operational density creates a flywheel with its own compounding logic. Higher volume justifies investment in faster fulfillment infrastructure, which improves delivery speed and reduces per-order shipping costs, which improves conversion rates, which drives higher volume. By 2023, Myprotein's average delivery time in the UK was 1.2 days — competitive with Amazon Prime — at an average shipping cost per order that analysts estimated at £2.50–3.50, roughly 30% below the industry average for DTC nutrition brands.
The Influencer Industrial Complex
Myprotein did not invent influencer marketing. But it may have perfected the industrialization of it. The brand operates one of the largest affiliate and influencer programs in consumer goods, with an estimated 5,000+ active affiliates and influencer partners globally as of 2023. The program's structure reveals something important about how Myprotein thinks about customer acquisition.
Rather than concentrating spend on a small number of elite fitness influencers — the Gymshark model, which involves six- and seven-figure retainers for athletes with millions of followers — Myprotein distributes its influencer budget across a vast long tail of micro- and nano-influencers. A typical Myprotein affiliate is a fitness enthusiast with 5,000–50,000 followers on Instagram or TikTok, a personal discount code offering 30–40% off, and a commission structure paying 6–10% on attributed sales. The cost per acquisition through this channel is remarkably low — estimated at £3–6 per new customer — because the influencer is essentially paying for their own product through the discount and earning a modest commission on conversions.
The mathematical elegance is that this structure converts customer acquisition cost into a variable cost that scales linearly with revenue, rather than a fixed cost (like traditional advertising) that must be committed upfront with uncertain return. When Myprotein runs a major promotional event — Black Friday, its January "New Year New Me" campaign, or the back-to-university September push — the affiliate network amplifies the promotion organically, because every affiliate's commission is tied to the same promotional offer. The company gets thousands of simultaneous social media posts pushing the same sale without paying for a single impression upfront.
The downside is quality control. With thousands of affiliates posting independently, brand messaging becomes diffuse, contradictory, and occasionally embarrassing. Myprotein affiliates have promoted products with inaccurate nutritional claims, made unauthorized health benefit assertions, and occasionally feuded publicly with each other in ways that reflected poorly on the brand. The company's compliance team — reportedly numbering fewer than 20 people as of 2022 — has struggled to monitor the output of a marketing army this large.
The Gymshark Problem
If Myprotein's competitive moat is price, Gymshark's moat is desire. And the collision between these two brands — both Manchester-born, both built on fitness culture, both leveraging DTC infrastructure and influencer networks — is one of the most instructive competitive dynamics in modern consumer goods.
Ben Francis founded Gymshark in 2012 at age 19, initially as a fitness apparel brand sold through BodyPower expo events. By 2020, Gymshark had raised $300 million from General Atlantic at a $1.3 billion valuation, generating approximately £400 million in revenue. The brand had achieved something that Myprotein, for all its scale, had not: genuine emotional resonance. Gymshark customers identified with the brand. They wore the logo publicly. They tattooed the shark. Myprotein customers, by contrast, bought Myprotein because it was cheap.
The competitive tension intensified when Gymshark launched its own nutrition line in 2022, directly challenging Myprotein's core category. Gymshark's protein products were priced at a 20–30% premium to Myprotein's promotional prices, but offered sleeker packaging, more aspirational branding, and the implicit endorsement of the Gymshark athlete roster. Early sales data suggested Gymshark's nutrition products were gaining traction among the brand's existing apparel customers — precisely the demographic that Myprotein had always struggled to retain once they "graduated" from price-sensitive purchasing to identity-driven consumption.
Myprotein's response was revealing. Rather than competing on brand aspiration — a fight it would lose — the company doubled down on product breadth and innovation. The catalog expanded aggressively into functional foods (high-protein ice cream, protein-enriched pasta, zero-calorie syrups), performance nutrition (nootropics, adaptogens, specialized pre-workouts), and a dramatically expanded clothing line that, while not matching Gymshark's cultural cachet, offered functional gym apparel at 40–50% lower price points.
The strategic bet is clear: Myprotein is wagering that the sports nutrition market is large enough and fragmented enough that owning the value position is not a consolation prize but the single largest addressable segment. Not everyone wants to pay £35 for a Gymshark protein pouch. Most people, in fact, don't. And in a cost-of-living crisis, the percentage who won't is growing.
The China Experiment and the Limits of Localization
Myprotein's expansion into China — initially via Tmall Global in 2019, then through WeChat mini-programs and Douyin (Chinese TikTok) commerce — represents both the brand's most ambitious international bet and its most humbling lesson in the limits of platform-driven localization.
The Chinese sports nutrition market is estimated at $8–10 billion annually, growing at 12–15% per year, driven by rising gym membership, government fitness initiatives, and the rapid expansion of the "fitness KOL" (key opinion leader) ecosystem on Chinese social platforms. Myprotein entered with its standard playbook: aggressive pricing, influencer seeding, and heavy promotional cadence. Early traction was promising — the brand reportedly generated over £30 million in Chinese revenue within its first two years.
But the market proved structurally different from Europe in ways that Myprotein's Ingenuity platform couldn't easily accommodate. Chinese consumers exhibited far less loyalty to Western supplement brands than anticipated, with domestic competitors like Muscletech (licensed for Chinese production), ON China, and a wave of local brands offering comparable products at lower prices with faster delivery via domestic fulfillment. More critically, the Chinese e-commerce ecosystem — dominated by Alibaba, JD.com, and increasingly Douyin — demands a level of platform-native content creation, livestream selling, and social commerce sophistication that THG's Ingenuity stack, optimized for Western DTC environments, was not designed to support.
By 2023, Myprotein's Chinese growth had slowed significantly, and the company had reportedly scaled back its dedicated China team. The lesson was not that China was unwinnable, but that the Ingenuity platform's advantage — its ability to rapidly replicate a Western DTC model across markets — became a liability in markets where the dominant commerce infrastructure was fundamentally different. Shopify-style DTC works in markets where customers navigate to branded websites. In China, customers live inside platform ecosystems, and the brand must come to them on the platform's terms.
Post-Pandemic Reckoning
The COVID-19 pandemic was, for approximately eighteen months, the greatest thing that ever happened to Myprotein. Gym closures drove a massive surge in home fitness spending. Protein powder, resistance bands, and home workout equipment became pandemic pantry staples. Myprotein's DTC model — already frictionless, already optimized for home delivery — was perfectly positioned. Revenue surged over 40% in 2020, with customer acquisition costs plummeting as organic search volume for home fitness products exploded.
Then the gyms reopened. And the hangover arrived.
The 2021–2023 period exposed every fragility in the Myprotein model simultaneously. Customer acquisition costs rebounded sharply as the organic pandemic demand evaporated and competitors — both DTC brands and Amazon private label — poured back into paid digital advertising. Whey protein input costs spiked as global dairy markets tightened, compressing product-level gross margins by an estimated 5–8 percentage points. And the promotional treadmill, which had been easy to sustain during a demand surge, became punishing during a normalization: the same 45% discounts now came with lower absolute volumes, meaning the revenue per promotional campaign was declining even as the promotional intensity remained constant.
THG's financial reporting, which consolidated Myprotein's results within the broader THG Nutrition division, revealed the strain. THG Nutrition's adjusted EBITDA margin, which had peaked at approximately 12% in 2020, compressed to roughly 6–8% by 2022. Revenue growth decelerated from 40%+ to low single digits. And the customer cohort analysis — never officially disclosed but discussed obliquely by analysts who covered the stock — suggested that pandemic-acquired customers had significantly lower lifetime values than pre-pandemic cohorts, having been acquired during an anomalous demand period and showing low repeat purchase rates once gyms reopened.
The company's response was a pivot toward what Myprotein internally called "premiumization within value" — an effort to shift the product mix toward higher-margin categories (clear whey, functional foods, clothing) while maintaining the brand's value positioning. Average order values were pushed upward through bundling strategies and free shipping thresholds. And a loyalty program, "MP Rewards," was introduced to create switching costs and incentivize repeat purchases without relying exclusively on discount codes.
Myprotein's strategic priority is the evolution from a value-led protein brand to a comprehensive sports nutrition and lifestyle ecosystem, anchored by product innovation and customer lifetime value optimization.
— THG FY2022 Annual Report
What the Pouch Knows
There is a detail about Myprotein that seems trivial but contains the entire strategic logic of the business. The pouch.
Since its founding, Myprotein has shipped its flagship products in resealable matte pouches — not the rigid plastic tubs favored by virtually every competitor from Optimum Nutrition to Ghost to Gymshark. The pouch is cheaper to produce (roughly 40% less than an equivalently sized tub), cheaper to ship (it conforms to box dimensions, reducing void fill and dimensional weight charges), cheaper to store (pouches stack flat, tubs do not), and more environmentally defensible (less plastic per unit of product). It is also, by any conventional branding standard, uglier. Less "shelfworthy." Less giftable. Less Instagrammable than a gleaming black tub with embossed logos.
Myprotein has kept the pouch anyway. Not because the company lacks the capability to switch — it sells some products in tubs and bottles — but because the pouch is the brand. The pouch communicates everything Myprotein wants the customer to believe: we spend money on what's inside, not what's outside. We are the un-premium premium. We are the brand for people who see through brands.
Every few years, according to former employees, the marketing team proposes a packaging refresh — sleeker pouches, more premium design, maybe a shift to tubs for key SKUs. And every few years, the commercial team kills it, armed with data showing that the pouch is one of Myprotein's most powerful conversion signals. In A/B tests, products shown in pouches consistently outperform the same products shown in tubs on Myprotein's own platform, because the pouch triggers the value association that drives the purchase decision. The pouch is not packaging. It is positioning made physical.
On a shelf in the Warrington facility, next to the production line that fills 60,000 pouches per day, there is reportedly a framed printout of Myprotein's first-ever online order from 2004 — a single 1kg pouch of unflavored whey protein, shipped to an address in Leeds, total price £9.99. The company that fulfills that order today ships to 70 countries, employs thousands, and generates more revenue than most publicly traded food companies. The pouch hasn't changed.